Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MA › BOSTON › DANA-FARBER CANCER INSTITUTE, INC.

DANA-FARBER CANCER INSTITUTE, INC.

NPI: 1851333686 · BOSTON, MA 02215 · General Acute Care Hospital · NPI assigned 06/13/2006

$240.21M
Total Medicaid Paid
2,372,309
Total Claims
1,591,423
Beneficiaries
357
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialDEMBINSKI, PAUL (SR. DIRECTOR OF PFS)
NPI Enumeration Date06/13/2006

Related Entities

Other providers sharing the same authorized official: DEMBINSKI, PAUL

ProviderCityStateTotal Paid
DANA-FARBER CANCER INSTITUTE, INC. BOSTON MA $4.81M
DANA-FARBER CANCER INSTITUTE, INC. BOSTON MA $24K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 258,114 $18.88M
2019 276,052 $22.13M
2020 296,963 $26.34M
2021 391,024 $36.11M
2022 393,533 $40.08M
2023 395,686 $49.80M
2024 360,937 $46.86M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
J9271 Injection, pembrolizumab, 1 mg 6,182 4,491 $33.02M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 123,385 80,896 $25.44M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 75,242 41,464 $13.14M
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg 5,051 3,462 $11.11M
J9299 Injection, nivolumab, 1 mg 2,754 1,817 $10.92M
J9035 Injection, bevacizumab, 10 mg 6,685 2,750 $8.80M
J2505 Injection, pegfilgrastim, 6 mg 3,900 2,804 $8.66M
96361 Intravenous infusion, hydration; each additional hour 21,276 13,046 $7.13M
J9355 Injection, trastuzumab, excludes biosimilar, 10 mg 3,381 2,351 $5.06M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 149,281 102,728 $4.62M
96415 14,913 9,021 $4.43M
J9306 Injection, pertuzumab, 1 mg 1,706 1,207 $4.30M
96375 Therapeutic injection; each additional sequential IV push 50,625 27,935 $4.05M
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj 1,656 1,024 $4.04M
80053 Comprehensive metabolic panel 190,810 121,680 $4.00M
36430 10,799 6,522 $3.69M
78815 Positron emission tomography (PET) for limited area imaging 3,602 3,371 $3.44M
J9358 Injection, fam-trastuzumab deruxtecan-nxki, 1 mg 1,252 630 $3.43M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 22,267 18,849 $3.17M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 19,265 14,947 $3.00M
J2796 Injection, romiplostim, 10 micrograms 3,634 1,144 $2.91M
J0185 Injection, aprepitant, 1 mg 12,866 8,090 $2.79M
74177 Computed tomography, abdomen and pelvis; with contrast material 11,796 11,322 $2.58M
J9217 Leuprolide acetate (for depot suspension), 7.5 mg 4,772 4,501 $2.30M
J9041 Injection, bortezomib, 0.1 mg 5,655 1,362 $2.19M
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 27,641 18,996 $2.18M
99215 Prolong outpt/office vis 9,620 8,182 $2.17M
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 12,847 7,553 $1.95M
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 11,466 9,827 $1.83M
J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg 3,086 1,674 $1.80M
J2469 Injection, palonosetron hcl, 25 mcg 19,705 11,507 $1.76M
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 5,500 3,744 $1.70M
71260 Computed tomography, thorax, diagnostic; with contrast material 13,698 13,106 $1.67M
J0897 Injection, denosumab, 1 mg 2,559 2,312 $1.55M
96367 14,148 9,361 $1.54M
96401 9,809 4,584 $1.50M
J1950 Injection, leuprolide acetate (for depot suspension), per 3.75 mg 1,279 1,197 $1.46M
J9395 Injection, fulvestrant, 25 mg 2,254 1,865 $1.41M
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 3,501 3,288 $1.41M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 197,766 130,093 $1.39M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 9,953 8,618 $1.33M
J9305 Injection, pemetrexed, not otherwise specified, 10 mg 783 519 $1.23M
96409 13,502 7,526 $1.16M
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 4,888 3,876 $1.15M
77386 4,867 467 $1.05M
J9263 Injection, oxaliplatin, 0.5 mg 5,806 3,375 $1.03M
96416 4,829 2,986 $987K
96411 16,429 10,648 $985K
99205 Prolong outpt/office vis 3,938 3,490 $954K
77412 3,682 394 $950K
J9312 Injection, rituximab, 10 mg 560 273 $852K
96417 19,594 12,247 $851K
80050 General health panel 11,294 9,320 $830K
38222 2,107 1,728 $741K
88185 3,805 3,151 $738K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 17,081 11,244 $710K
J9070 Cyclophosphamide, 100 mg 3,028 1,717 $652K
83735 82,349 48,670 $630K
J2353 Injection, octreotide, depot form for intramuscular injection, 1 mg 252 209 $563K
Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg 242 104 $537K
Q2050 Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg 294 265 $512K
77067 Screening mammography, bilateral, including computer-aided detection 11,329 11,131 $508K
J1453 Injection, fosaprepitant, 1 mg 1,498 963 $485K
77063 Screening digital breast tomosynthesis, bilateral 8,026 7,896 $482K
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg 4,195 2,109 $481K
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 2,280 1,405 $464K
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units 2,641 1,168 $460K
96402 10,255 9,260 $451K
P9040 Red blood cells, leukocytes reduced, irradiated, each unit 7,460 5,188 $443K
96368 9,396 5,723 $430K
82378 25,047 17,833 $427K
J1756 Injection, iron sucrose, 1 mg 7,652 4,379 $411K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 1,860 1,813 $337K
77336 3,740 1,621 $335K
86850 28,659 15,061 $315K
J9354 Injection, ado-trastuzumab emtansine, 1 mg 181 75 $310K
J3490 Unclassified drugs 15,622 8,376 $289K
J1750 Injection, iron dextran, 50 mg 1,968 1,323 $287K
ATP14 35,891 21,994 $282K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 14,183 13,499 $278K
82784 20,154 16,352 $273K
96450 397 278 $267K
82728 27,350 25,245 $258K
J9316 Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg 34 25 $250K
31575 1,322 1,204 $238K
P9037 Platelets, pheresis, leukocytes reduced, irradiated, each unit 1,067 535 $236K
87497 6,352 3,675 $231K
J9022 Injection, atezolizumab, 10 mg 36 25 $229K
J9206 Injection, irinotecan, 20 mg 5,148 2,642 $227K
J2997 Injection, alteplase recombinant, 1 mg 1,967 1,707 $210K
86923 6,783 4,647 $204K
86300 9,877 7,619 $194K
86900 29,436 15,536 $193K
99443 1,510 1,349 $191K
Q5117 Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg 61 47 $188K
J0640 Injection, leucovorin calcium, per 50 mg 10,852 6,125 $186K
86901 28,897 15,200 $186K
74183 818 783 $185K
78816 258 235 $167K
84100 46,585 28,530 $156K
86304 9,166 6,654 $155K
87799 2,424 1,043 $154K
83615 42,578 29,290 $153K
J9310 Injection, rituximab, 100 mg 142 89 $150K
85027 22,468 13,242 $147K
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion 2,892 1,767 $143K
80048 Basic metabolic panel (calcium, ionized) 7,368 5,380 $136K
86334 11,808 9,889 $136K
96377 4,677 3,566 $134K
88184 3,824 3,196 $134K
84439 12,324 10,234 $130K
83550 19,150 18,153 $128K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 5,974 5,488 $127K
J9264 Injection, paclitaxel protein-bound particles, 1 mg 184 61 $123K
97803 1,307 979 $118K
76642 1,326 1,234 $107K
83540 22,539 21,251 $107K
J3489 Injection, zoledronic acid, 1 mg 4,908 4,573 $104K
80076 5,442 4,145 $103K
A9585 Injection, gadobutrol, 0.1 ml 6,442 6,079 $100K
78306 608 582 $100K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 383 374 $91K
ATP15 11,765 7,631 $91K
86301 5,804 3,732 $91K
82248 22,530 12,663 $89K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 3,575 3,322 $89K
88305 Level IV - Surgical pathology, gross and microscopic examination 2,887 2,468 $88K
82607 8,676 8,327 $80K
83521 6,249 4,966 $77K
83520 11,100 4,986 $75K
81162 56 55 $74K
Q5115 Injection, rituximab-abbs, biosimilar, (truxima), 10 mg 27 12 $73K
84443 Thyroid stimulating hormone (TSH) 12,680 10,675 $70K
85007 18,756 10,546 $70K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 5,005 3,952 $68K
71250 1,440 1,377 $65K
84702 3,419 2,629 $62K
88237 1,025 877 $61K
84153 8,323 7,452 $61K
84165 12,747 10,709 $60K
88342 1,547 1,355 $59K
J9171 Injection, docetaxel, 1 mg 497 266 $54K
84403 5,417 4,927 $54K
J9267 Injection, paclitaxel, 1 mg 8,714 3,855 $51K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 18,200 9,922 $48K
70491 384 364 $48K
J9045 Injection, carboplatin, 50 mg 6,334 4,258 $44K
88108 507 382 $42K
J9190 Injection, fluorouracil, 500 mg 15,353 6,368 $40K
88313 2,050 1,541 $37K
80197 3,989 2,023 $37K
85610 8,068 6,254 $36K
72197 104 101 $36K
81001 10,020 7,804 $35K
86803 2,162 1,880 $34K
J2405 Injection, ondansetron hydrochloride, per 1 mg 9,439 5,436 $34K
82746 3,923 3,766 $34K
J9173 Injection, durvalumab, 10 mg 34 24 $33K
88341 250 230 $33K
ATP16 4,609 2,637 $32K
86141 3,229 2,772 $32K
82150 4,215 2,511 $31K
88262 233 204 $31K
80061 Lipid panel 3,577 3,146 $30K
71046 Radiologic examination, chest; 2 views 1,252 1,136 $29K
J9145 Injection, daratumumab, 10 mg 74 26 $29K
85045 9,867 7,445 $29K
77049 38 37 $29K
96376 4,444 3,396 $28K
84550 11,397 7,259 $28K
86360 887 770 $28K
86704 2,005 1,757 $27K
82232 3,384 2,935 $27K
36593 649 587 $27K
87340 2,425 2,126 $27K
82105 2,171 1,812 $26K
J9370 Vincristine sulfate, 1 mg 5,792 3,710 $25K
90686 1,536 1,445 $25K
85730 5,341 4,276 $24K
J9000 Injection, doxorubicin hydrochloride, 10 mg 3,021 1,912 $24K
82565 6,022 4,651 $24K
83690 3,300 2,205 $22K
J8540 Dexamethasone, oral, 0.25 mg 30,171 15,784 $22K
88311 1,559 1,300 $22K
82247 5,724 2,899 $22K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 122 106 $22K
99195 744 595 $21K
97802 379 343 $21K
J1190 Injection, dexrazoxane hydrochloride, per 250 mg 20 13 $21K
87086 Culture, bacterial; quantitative colony count, urine 2,680 2,350 $19K
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg 3,239 2,134 $19K
81206 225 198 $19K
89051 1,055 668 $19K
ATP17 2,844 1,678 $19K
J1200 Injection, diphenhydramine hcl, up to 50 mg 10,233 6,075 $18K
84450 4,440 2,364 $18K
77387 668 79 $17K
J9999 Not otherwise classified, antineoplastic drugs 156 125 $17K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 11,971 6,782 $17K
81003 3,475 2,112 $17K
86355 651 575 $16K
J9075 Injection, cyclophosphamide, not otherwise specified, 5 mg 148 101 $16K
J1439 Injection, ferric carboxymaltose, 1 mg 18 13 $15K
J3475 Injection, magnesium sulfate, per 500 mg 9,955 5,426 $15K
0002A 766 732 $15K
86706 1,958 1,788 $15K
77062 138 132 $14K
77066 Tomosynthesis, mammo 770 736 $14K
86357 601 527 $14K
85055 495 219 $14K
77065 Tomosynthesis, mammo 428 415 $13K
99442 166 140 $12K
0001A 780 750 $12K
83036 Hemoglobin; glycosylated (A1C) 2,203 2,046 $12K
84520 3,167 2,457 $11K
J9060 Injection, cisplatin, powder or solution, 10 mg 2,177 1,053 $10K
81450 60 53 $10K
87449 737 440 $10K
86140 1,407 1,198 $9K
77061 100 99 $9K
80051 529 382 $8K
J9250 Methotrexate sodium, 5 mg 3,144 1,594 $8K
ATP03 2,978 2,027 $8K
85652 3,072 2,690 $8K
J3480 Injection, potassium chloride, per 2 meq 5,475 2,844 $8K
84466 1,834 1,684 $8K
82670 349 334 $8K
87305 624 371 $8K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 1,613 1,465 $7K
82533 403 344 $7K
J0461 Injection, atropine sulfate, 0.01 mg 4,342 2,387 $7K
ATP09 1,116 607 $7K
82550 1,685 1,236 $7K
84156 3,151 2,519 $6K
96523 157 146 $6K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 71 57 $6K
82570 2,386 1,820 $6K
J9071 Injection, cyclophosphamide (auromedics), 5 mg 102 54 $6K
82947 1,012 748 $5K
81265 46 37 $5K
74176 Computed tomography, abdomen and pelvis; without contrast material 96 93 $5K
86335 914 801 $5K
83001 309 291 $5K
83010 900 771 $5K
J9181 Injection, etoposide, 10 mg 1,063 298 $5K
94010 219 208 $5K
86356 112 80 $5K
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 8,640 5,025 $4K
36591 460 323 $4K
94726 134 126 $4K
86769 246 208 $4K
83789 252 242 $4K
ATP02 1,237 914 $4K
85044 1,295 1,093 $4K
G0008 Administration of influenza virus vaccine 995 947 $4K
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 1,203 888 $3K
94729 135 127 $3K
81267 78 63 $3K
84166 1,092 971 $3K
J9260 Injection, methotrexate sodium, 50 mg 525 258 $3K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring 12 12 $3K
86644 134 109 $3K
J1170 Injection, hydromorphone, up to 4 mg 916 583 $3K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 162 149 $3K
87040 254 174 $3K
81025 344 253 $3K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 161 147 $2K
0003A 144 143 $2K
96040 26 24 $2K
90662 364 342 $2K
J2704 Injection, propofol, 10 mg 781 589 $2K
ATP18 300 167 $2K
88381 39 38 $2K
85097 96 80 $2K
86316 223 194 $2K
77300 12 12 $2K
86665 65 39 $2K
J9100 Injection, cytarabine, 100 mg 262 114 $2K
90677 13 12 $2K
ATP08 284 217 $2K
82668 302 285 $2K
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg 25 13 $2K
0004A 105 90 $2K
S0028 Injection, famotidine, 20 mg 52 29 $1K
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 5,079 4,343 $1K
36592 160 96 $1K
99417 Prolong home eval add 15m 31 27 $1K
82610 159 145 $1K
87081 518 478 $1K
72158 12 12 $1K
81268 46 24 $1K
88360 39 37 $1K
86922 205 116 $1K
M0220 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring 16 14 $1K
87631 35 26 $1K
86945 44 26 $1K
86777 53 50 $995.93
84481 134 109 $918.32
J3010 Injection, fentanyl citrate, 0.1 mg 1,002 779 $870.79
84155 1,259 1,117 $858.25
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 29 27 $825.00
Q3014 Telehealth originating site facility fee 1,577 1,444 $816.74
83516 112 65 $777.63
J2060 Injection, lorazepam, 2 mg 823 534 $772.81
90656 49 45 $717.46
86359 56 52 $711.26
ATP07 133 94 $710.64
Q0164 Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 2,648 1,520 $676.27
84478 250 159 $653.96
84460 145 102 $628.85
88271 88 65 $613.55
86787 40 38 $604.61
82043 198 168 $569.13
88275 21 13 $538.46
93000 13 13 $532.81
90472 Immunization administration, each additional vaccine (list separately) 185 168 $485.08
84484 31 25 $413.42
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries 622 592 $412.83
87077 78 62 $380.46
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 17 14 $380.40
85384 78 59 $361.78
86039 41 41 $319.32
J2919 Injection, methylprednisolone sodium succinate, 5 mg 247 151 $289.75
86902 32 25 $276.01
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 29 27 $275.00
87186 13 12 $257.11
83021 24 24 $223.02
90670 19 12 $213.35
83883 32 25 $205.20
86664 13 13 $202.41
88365 15 12 $143.21
83880 20 13 $138.48
84480 27 25 $137.75
82310 183 125 $136.37
0077U 463 430 $116.94
83970 24 18 $109.23
86431 12 12 $75.50
83020 17 12 $68.10
82977 204 144 $62.70
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 19 14 $58.55
85049 37 36 $44.99
82465 42 37 $44.88
91300 688 556 $40.50
82374 45 33 $25.14
84132 52 40 $24.39
85018 37 36 $23.76
85014 36 35 $21.60
85651 16 15 $18.25
ATP13 15 13 $10.89
85041 13 13 $8.28
84295 17 16 $0.00
J7030 Infusion, normal saline solution , 1000 cc 78 44 $0.00
Q0220 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg 16 14 $0.00
77417 76 36 $0.00
J1940 Injection, furosemide, up to 20 mg 36 24 $0.00
G0009 Administration of pneumococcal vaccine 12 12 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 12 12 $0.00